News

October 1, 2010 – The most recent clinical data from USpella, a U.S. multicenter, observational registry of patients who received percutaneous cardiac support from the Impella 2.5 device, was...

September 30, 2010 – A specialized partner program was recently launched to enable select top healthcare institutions to provide advanced training in hemodynamic support and complex patient...

September 21, 2010 – Ventricular assist devices (VADs) can restore normal hemodynamics and support recovery of native cardiac function after acute myocardial infarction (AMI), according to a study...

September 20, 2010 – Transcatheter ventricular assist device (VAD) company Abiomed will highlight its devices at several events during the 2010 Transcatheter Cardiovascular Therapeutics (TCT)...

September 10, 2010 – The first patient was successfully supported for six days by the Impella Right Peripheral (RP) ventricular assist device (VAD) at the Providence Heart and Lung Institute at St...

September 2, 2010 – Artificial heart maker SynCardia Systems said it plans to put the company up for sale some time in the next two years.

August 13, 2010 – A rotary blood pump designed for long-term patient support had another patient surpass four years after receiving the left ventricular assist device (LVAD). Helga Gieseke, 66,...

August 11, 2010 – The Bluhm Cardiovascular Institute of Northwestern Memorial Hospital recently implanted a patient with two of the smallest experimental ventricular assist devices (VADs)...

August 3, 2010 — Patients have the right to refuse or request the withdrawal of any unwanted medical treatment. In an article published in the online issue of Mayo Clinic Proceedings,...

June 16, 2010 – A ventricular assist system has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin a new clinical trial. HeartWare International Inc.

March 30, 2010 – The FDA granted an investigational device exemption (IDE) for a clinical study of the Freedom portable driver system to power SynCardia's Total Artificial Heart. The study is...

March 9, 2010 – During the American College of Cardiology (ACC) 59th Annual Scientific Session, March 14-16, CardiacAssist will host its “Clinical Innovations in TandemHeart Support Symposium and...

January 27, 2010 – Robust blood pressure measurements via fiberoptic sensors will be added to the Abiomed Impella percutaneous ventricular assist device (P-VAD).

January 27, 2010 – A German study enrolled its first 20 patients to investigate the utility of muscular counter pulsation (MCP) in patients with early-stage heart failure.

January 26, 2010 – Surgical ventricular assist device (VAD) maker Thoratec Corp. acquired a catheter-based pump technology and plans to develop a minimally invasive, axial flow pump that can be...

January 21, 2010 – The FDA this week cleared the HeartMate II, a continuous-flow, left ventricular assist device (VAD), as a support for severe heart failure patients who are not acceptable...

December 18, 2009 – Results from the Europella registry, evaluating the safety and feasibility of the Abiomed Impella 2.5 circulatory assist device in high-risk percutaneous coronary intervention...

November 6, 2009 – Cardiac support device maker Abiomed Inc. yesterday announced second quarter fiscal 2010 revenue of $20 million.

November 3, 2009 — CardiacAssist Inc. said yesterday the Cardiovascular Institute of Stanford University Hospital and Clinics in Palo Alto, Calif., is one of the newest cardiac centers to begin...

October 22, 2009 – MAQUET Cardiovascular LLC said today it received European CE mark for the company's MEGA 8 Fr. 50 cc intra-aortic balloon (IAB) catheter.